A comparison of continuous subcutaneous insulin infusion vs. Multiple daily insulin injection in children with type I diabetes in Kuwait: Glycemic control, insulin requirement, and BMI

Oman Medical Journal

Volumn 30, Issue 5, 2015, Pages 336-343

  Abdulrasoul, Majedah M ^a   Mousa, Mohammad ^a   Al Mahdi, Maria ^b   Al Sanaa, Hala ^c   Al AbdulRazzaq, Dalia ^a   Al Kandari, Hessa ^d  

^a KUWAIT UNIVERSITY   (Kuwait)

^b ADAN HOSPITAL   (Kuwait)

^c AL AMIRI HOSPITAL   (Kuwait)

^d FARWANIYA HOSPITAL   (Kuwait)

Author keywords

Adolescent; Body mass index; Child; Diabetes mellitus; Glycosylated; Hemoglobin A; Insulin infusion systems; Type I

Indexed keywords

INSULIN;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; DIABETIC KETOACIDOSIS; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; QUALITY OF LIFE ASSESSMENT;

EID: 84941635370     PISSN: 1999768X     EISSN: 20705204     Source Type: Journal    
DOI: 10.5001/omj.2015.69     Document Type: Article

References (37)

1. Diabetes Atlas-IDF. International Diabetes Federation, 4th Edition. 2013.
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993 Sep;329(14):977-986.
3. Kordonouri O, Hartmann R, Danne T. Treatment of type 1 diabetes in children and adolescents using modern insulin pumps. Diabetes Res Clin Pract 2011 Aug;93(Suppl 1):S118-S124.
4. Skinner TC, Cameron FJ. Improving glycaemic control in children and adolescents: which aspects of therapy really matter? Diabet Med 2010 Apr;27(4):369-375.
5. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy: a meta-analysis. Diabetes Care 2003 Apr;26(4):1079-1087.
6. Weintrob N, Benzaquen H, Galatzer A, Shalitin S, Lazar L, Fayman G, et al. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial. Pediatrics 2003 Sep;112(3 Pt 1):559-564.
7. DiMeglio LA, Pottorff TM, Boyd SR, France L, Fineberg N, Eugster EA. A randomized, controlled study of insulin pump therapy in diabetic preschoolers. J Pediatr 2004 Sep;145(3):380-384.
8. Pickup J, Mattock M, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. BMJ 2002 Mar;324(7339):705.
9. Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care 1999 Nov;22(11):1779-1784.
10. Plotnick LP, Clark LM, Brancati FL, Erlinger T. Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Care 2003 Apr;26(4):1142-1146.
11. Battelino T. Risk and benefits of continuous subcutaneous insulin infusion (CSII) treatment in school children and adolescents. Pediatr Diabetes 2006 Aug;7(Suppl 4):20-24.
12. Hanas R, Lindgren F, Lindblad B. A 2-yr national population study of pediatric ketoacidosis in Sweden: predisposing conditions and insulin pump use. Pediatr Diabetes 2009 Feb;10(1):33-37.
13. Shaltout A, Abdulrasoul M, AlKandari H, AlMahdi M, AlKhawari M. Incidence of type 1 diabetes in children and adolescents (0-19 years) in Kuwait. National Diabetes Registry Data. (Unpublished Data)
14. Global IDF/ISPAD Guideline for Diabetes in childhood and Adolescents. International Diabetes Federation, 2011; 9-15.
15. Weinzimer SA, Swan KL, Sikes KA, Ahern JH. Emerging evidence for the use of insulin pump therapy in infants, toddlers, and preschool-aged children with type 1 diabetes. Pediatr Diabetes 2006 Aug;7(Suppl 4):15-19.
16. Johnson SR, Cooper MN, Jones TW, Davis EA. Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case-control study. Diabetologia 2013 Nov;56(11):2392-2400.
17. Pickup J, Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 2002 Mar;25(3):593-598.
18. Sulli N, Shashaj B. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up. Diabet Med 2006 Aug;23(8):900-906.
19. Jakisch BI, Wagner VM, Heidtmann B, Lepler R, Holterhus PM, Kapellen TM, et al; German/Austrian DPV Initiative and Working Group for Paediatric Pump Therapy. Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched-pair cohort analysis over 3 years. Diabet Med 2008 Jan;25(1):80-85.
20. Jeitler K, Horvath K, Berghold A, Gratzer TW, Neeser K, Pieber TR, et al. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients Majedah with diabetes mellitus: systematic review and meta-analysis. Diabetologia 2008 Jun;51(6):941-951.
21. Mameli C, Scaramuzza AE, Ho J, Cardona-Hernandez R, Suarez-Ortega L, Zuccotti GV. A 7-year follow-up retrospective, international, multicenter study of insulin pump therapy in children and adolescents with type 1 diabetes. Acta Diabetol 2014 Apr;51(2):205-210.
22. Shalitin S, Gil M, Nimri R, de Vries L, Gavan MY, Phillip M. Predictors of glycaemic control in patients with Type 1 diabetes commencing continuous subcutaneous insulin infusion therapy. Diabet Med 2010 Mar;27(3):339-347.
23. Deiss D, Hartmann R, Hoeffe J, Kordonouri O. Assessment of glycemic control by continuous glucose monitoring system in 50 children with type 1 diabetes starting on insulin pump therapy. Pediatr Diabetes 2004 Sep;5(3):117-121.
24. Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 2004 Jul;27(7):1554-1558.
25. Ahern JA, Boland EA, Doane R, Ahern JJ, Rose P, Vincent M, et al. Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbA1c levels across all age groups. Pediatr Diabetes 2002 Mar;3(1):10-15.
26. Batajoo RJ, Messina CR, Wilson TA. Long-term efficacy of insulin pump therapy in children with type 1 diabetes mellitus. J Clin Res Pediatr Endocrinol 2012 Sep;4(3):127- 131.
27. Sulli N, Shashaj B. Continuous subcutaneous insulin infusion in children and adolescents with diabetes mellitus: decreased HbA1c with low risk of hypoglycemia. J Pediatr Endocrinol Metab 2003 Mar;16(3):393-399.
28. Shalitin S, Gil M, Nimri R, de Vries L, Gavan MY, Phillip M. Predictors of glycaemic control in patients with Type 1 diabetes commencing continuous subcutaneous insulin infusion therapy. Diabet Med 2010 Mar;27(3):339-347.
29. Pinhas-Hamiel O, Tzadok M, Hirsh G, Boyko V, Graph- Barel C, Lerner-Geva L, et al. The impact of baseline hemoglobin A1c levels prior to initiation of pump therapy on long-term metabolic control. Diabetes Technol Ther 2010 Jul;12(7):567-573.
30. Johannesen J, Eising S, Kohlwes S, Riis S, Beck M, Carstensen B, et al. Treatment of Danish adolescent diabetic patients with CSII - a matched study to MDI. Pediatr Diabetes 2008 Feb;9(1):23-28.
31. Hathout EH, McClintock T, Sharkey J, Kytsenko D, Hartwick N, Hadley-Scofield M, et al. Glycemic, auxologic, and seasonal aspects of continuous subcutaneous insulin infusion therapy in children and young adults with type 1 diabetes. Diabetes Technol Ther 2003;5(2):175-181.
32. Fendler W, Baranowska AI, Mianowska B, Szadkowska A, Mlynarski W. Three-year comparison of subcutaneous insulin pump treatment with multi-daily injections on HbA1c, its variability and hospital burden of children with type 1 diabetes. Acta Diabetol 2012 Oct;49(5):363-370.
33. Ministry of Health. Kuwait. Administration of Food and Nutrition, 2013. Kuwait Nutrition Surveillance System 2007-2013 report.
34. Raile K, Noelle V, Landgraf R, Schwarz HP. Weight in adolescents with type 1 diabetes mellitus during continuous subcutaneous insulin infusion (CSII) therapy. J Pediatr Endocrinol Metab 2002 May;15(5):607-612.
35. Willi SM, Planton J, Egede L, Schwarz S. Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes. J Pediatr 2003 Dec;143(6):796-801.
36. Bin-Abbas BS, Sakati NA, Raef H, Al-Ashwal AA. Continuous subcutaneous insulin infusion in type 1 diabetic Saudi children. A comparison with conventional insulin therapy. Saudi Med J 2005 Jun;26(6):918-922.
37. Karagianni P, Sampanis Ch, Katsoulis Ch, Miserlis G, Polyzos S, Zografou I, et al. Continuous subcutaneous insulin infusion versus multiple daily injections. Hippokratia 2009 Apr;13(2):93-96.